iOMEDICO AG
↗Freiburg, Germany
iOMEDICO is an international, full-service Clinical Research Organization (CRO) and research institute specialized in oncology and hematology. Founded by oncologists, the company bridges the gap between clinical practice and advanced research by providing services ranging from study design to publication, with a strong focus on real-world data (RWD) and digital health solutions.
The company operates a large, high-performing oncology network with access to over 950 research sites in Germany and across Europe. They leverage proprietary electronic data capture (EDC) systems and AI-powered platforms to manage clinical trials (Phase I-IV) and prospective tumor registries, aiming to improve patient care and accelerate the development of innovative therapies.
CLASSIFICATION
SIZE & FINANCIALS
Employees:51-200
Founded:1996
Ownership:private
Status:operating
CORPORATE STRUCTURE
Key Partnerships:PhaseV (Collaboration on ML-powered solutions for Phase 3 oncology trials)
COMPETITION
Position:Niche Player
Competitors:OnCusp, CancerVax, Linical, Medelis
LEADERSHIP
Key Executives:
Michael Pröschel - CEO
Dr. med. Norbert Marschner - CSO
Sybille Marschner - CHRO
Scientific Founders:Dr. med. Norbert Marschner, Sybille Marschner
LINKS
Website:iomedico.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of iOMEDICO AG and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with iOMEDICO AG. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.